O	O	O	0	8	Impaired	Impaired	B-NP	JJ	O	2	NMOD	O
O	O	O	9	18	induction	induction	I-NP	NN	O	0	ROOT	O
O	O	O	19	21	of	of	B-PP	IN	O	2	NMOD	O
T1	B-Protein	B-Protein	22	23	c	c	B-NP	NN	B-DNA	11	NMOD	B-DNA
T1	I-Protein	I-Protein	23	24	-	-	I-NP	HYPH	I-DNA	11	NMOD	I-DNA
T1	I-Protein	I-Protein	24	27	fos	fos	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	O	27	28	/	/	B-NP	SYM	I-DNA	11	NMOD	I-DNA
T2	B-Protein	B-Protein	28	29	c	c	I-NP	NN	I-DNA	11	NMOD	I-DNA
T2	I-Protein	I-Protein	29	30	-	-	B-NP	HYPH	I-DNA	11	NMOD	I-DNA
T2	I-Protein	I-Protein	30	33	jun	jun	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	O	34	39	genes	gene	I-NP	NNS	I-DNA	3	PMOD	I-DNA
O	O	O	40	43	and	and	B-PP	CC	O	3	PMOD	O
O	O	O	44	46	of	of	B-PP	IN	O	3	PMOD	O
O	O	O	47	62	transcriptional	transcriptional	B-NP	JJ	B-protein	16	NMOD	B-protein
O	O	O	63	73	regulatory	regulatory	I-NP	JJ	I-protein	16	NMOD	I-protein
O	O	O	74	82	proteins	protein	I-NP	NNS	I-protein	13	PMOD	I-protein
O	O	O	83	90	binding	bind	B-VP	VBG	O	16	NMOD	O
O	O	O	91	99	distinct	distinct	B-NP	JJ	O	27	NMOD	O
T3	B-Protein	B-Protein	100	101	c	c	I-NP	NN	B-DNA	27	NMOD	B-DNA
T3	I-Protein	I-Protein	101	102	-	-	B-NP	HYPH	I-DNA	27	NMOD	I-DNA
T3	I-Protein	I-Protein	102	105	fos	fos	I-NP	NN	I-DNA	27	NMOD	I-DNA
O	O	O	105	106	/	/	B-NP	SYM	I-DNA	27	NMOD	I-DNA
T4	B-Protein	B-Protein	106	107	c	c	I-NP	NN	I-DNA	27	NMOD	I-DNA
T4	I-Protein	I-Protein	107	108	-	-	O	HYPH	I-DNA	27	NMOD	I-DNA
T4	I-Protein	I-Protein	108	111	jun	jun	B-NP	NN	I-DNA	27	NMOD	I-DNA
T27	B-Entity	B-Entity	112	120	promoter	promoter	I-NP	NN	I-DNA	27	NMOD	I-DNA
T27	I-Entity	I-Entity	121	129	elements	element	I-NP	NNS	I-DNA	17	OBJ	I-DNA
O	O	O	130	132	in	in	B-PP	IN	O	27	NMOD	O
O	O	O	133	142	activated	activate	B-NP	VBN	B-cell_type	32	NMOD	B-cell_type
O	O	O	143	148	human	human	I-NP	JJ	I-cell_type	32	NMOD	I-cell_type
O	O	O	149	150	T	T	I-NP	NN	I-cell_type	32	NMOD	I-cell_type
O	O	O	151	156	cells	cell	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	O	157	163	during	during	B-PP	IN	O	2	NMOD	O
O	O	O	164	169	aging	aging	B-NP	NN	O	33	PMOD	O
O	O	O	169	170	.	.	O	.	O	2	P	O

O	O	O	172	175	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	176	186	activation	activation	I-NP	NN	O	16	SUB	O
O	O	O	187	189	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	190	205	transcriptional	transcriptional	B-NP	JJ	B-protein	6	NMOD	B-protein
O	O	O	206	212	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
T5	B-Protein	B-Protein	213	214	c	c	I-NP	NN	O	3	PMOD	O
T5	I-Protein	I-Protein	214	215	-	-	B-NP	HYPH	O	2	NMOD	O
T5	I-Protein	I-Protein	215	218	Fos	Fos	I-NP	NN	B-protein	7	PMOD	B-protein
O	O	O	218	219	/	/	B-NP	SYM	O	8	NMOD	O
T6	B-Protein	B-Protein	219	220	c	c	I-NP	NN	O	9	PMOD	O
T6	I-Protein	I-Protein	220	221	-	-	O	HYPH	O	10	NMOD	O
T6	I-Protein	I-Protein	221	224	Jun	Jun	B-NP	NN	B-protein	13	NMOD	B-protein
T28	B-Entity	B-Entity	225	227	AP	AP	I-NP	NN	I-protein	14	NMOD	I-protein
T28	I-Entity	I-Entity	227	228	-	-	B-NP	HYPH	O	11	SBAR	O
T28	I-Entity	I-Entity	228	229	1	1	I-NP	CD	O	14	NMOD	O
O	O	O	230	232	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	233	242	essential	essential	B-ADJP	JJ	O	16	PRD	O
O	O	O	243	246	for	for	B-PP	IN	O	17	AMOD	O
O	O	O	247	253	normal	normal	B-NP	JJ	O	22	NMOD	O
O	O	O	254	255	T	T	I-NP	NN	O	22	NMOD	O
O	O	O	256	260	cell	cell	I-NP	NN	O	22	NMOD	O
O	O	O	261	275	responsiveness	responsiveness	I-NP	NN	O	18	PMOD	O
O	O	O	276	279	and	and	O	CC	O	16	VMOD	O
O	O	O	280	282	is	be	B-VP	VBZ	O	16	VMOD	O
O	O	O	283	288	often	often	B-ADVP	RB	O	24	VMOD	O
O	O	O	289	297	impaired	impaired	B-ADJP	JJ	O	24	PRD	O
O	O	O	298	300	in	in	B-PP	IN	O	26	AMOD	O
O	O	O	301	302	T	T	B-NP	NN	B-cell_type	29	NMOD	B-cell_type
O	O	O	303	308	cells	cell	I-NP	NNS	I-cell_type	27	PMOD	I-cell_type
O	O	O	309	315	during	during	B-PP	IN	O	26	AMOD	O
O	O	O	316	321	aging	aging	B-NP	NN	O	30	PMOD	O
O	O	O	321	322	.	.	O	.	O	16	P	O

O	O	O	323	325	In	In	B-PP	IN	O	7	VMOD	O
O	O	O	326	329	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	330	337	present	present	I-NP	JJ	O	4	NMOD	O
O	O	O	338	343	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	343	344	,	,	O	,	O	7	P	O
O	O	O	345	347	we	we	B-NP	PRP	O	7	SUB	O
O	O	O	348	360	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	O	361	368	whether	whether	B-SBAR	IN	O	7	VMOD	O
O	O	O	369	380	aberrancies	aberrancy	B-NP	NNS	O	27	SUB	O
O	O	O	381	383	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	384	387	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	388	398	regulation	regulation	I-NP	NN	O	10	PMOD	O
O	O	O	399	401	of	of	B-PP	IN	O	12	NMOD	O
T7	B-Protein	B-Protein	402	403	c	c	B-NP	NN	B-DNA	20	NMOD	B-DNA
T7	I-Protein	I-Protein	403	404	-	-	I-NP	HYPH	I-DNA	20	P	I-DNA
T7	I-Protein	I-Protein	404	407	fos	fos	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	O	407	408	/	/	B-NP	SYM	O	20	P	O
T8	B-Protein	B-Protein	408	409	c	c	I-NP	NN	B-DNA	20	NMOD	B-DNA
T8	I-Protein	I-Protein	409	410	-	-	B-NP	HYPH	I-DNA	20	NMOD	I-DNA
T8	I-Protein	I-Protein	410	413	jun	jun	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	414	416	at	at	B-PP	IN	O	12	NMOD	O
O	O	O	417	420	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	421	425	mRNA	mRNA	I-NP	NN	B-RNA	26	NMOD	B-RNA
O	O	O	426	428	or	or	I-NP	CC	O	26	NMOD	O
O	O	O	429	436	protein	protein	I-NP	NN	O	26	NMOD	O
O	O	O	437	442	level	level	I-NP	NN	O	21	PMOD	O
O	O	O	443	448	might	might	B-VP	MD	O	8	SBAR	O
O	O	O	449	457	underlie	underlie	I-VP	VB	O	27	VC	O
O	O	O	458	461	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	462	465	age	age	I-NP	NN	O	33	NMOD	O
O	O	O	465	466	-	-	B-NP	HYPH	O	33	NMOD	O
O	O	O	466	476	associated	associate	I-NP	VBN	O	33	NMOD	O
O	O	O	477	488	impairments	impairment	I-NP	NNS	O	28	OBJ	O
O	O	O	489	491	of	of	B-PP	IN	O	33	NMOD	O
T29	B-Entity	B-Entity	492	494	AP	AP	B-NP	NN	B-protein	36	NMOD	B-protein
T29	I-Entity	I-Entity	494	495	-	-	B-NP	HYPH	I-protein	34	PMOD	I-protein
T29	I-Entity	I-Entity	495	496	1	1	I-NP	CD	I-protein	36	NMOD	I-protein
O	O	O	497	499	in	in	B-PP	IN	O	33	NMOD	O
O	O	O	500	505	human	human	B-NP	JJ	B-cell_type	41	NMOD	B-cell_type
O	O	O	506	507	T	T	I-NP	NN	I-cell_type	41	NMOD	I-cell_type
O	O	O	508	513	cells	cell	I-NP	NNS	I-cell_type	38	PMOD	I-cell_type
O	O	O	513	514	.	.	O	.	O	7	P	O

O	O	O	515	522	Whereas	Whereas	B-SBAR	IN	O	47	VMOD	O
O	O	O	523	524	T	T	B-NP	NN	B-cell_type	3	NMOD	B-cell_type
O	O	O	525	530	cells	cell	I-NP	NNS	I-cell_type	26	SUB	I-cell_type
O	O	O	531	535	from	from	B-PP	IN	O	3	NMOD	O
O	O	O	536	541	young	young	B-NP	JJ	O	6	NMOD	O
O	O	O	542	550	subjects	subject	I-NP	NNS	O	4	PMOD	O
O	O	O	551	561	stimulated	stimulate	B-VP	VBN	O	6	NMOD	O
O	O	O	562	566	with	with	B-PP	IN	O	7	VMOD	O
O	O	O	567	572	cross	cross	B-NP	AFX	O	8	PMOD	O
O	O	O	572	573	-	-	B-VP	HYPH	O	9	NMOD	O
O	O	O	573	579	linked	link	I-VP	VBN	O	10	VC	O
O	O	O	580	584	anti	anti	B-NP	AFX	O	18	NMOD	O
O	O	O	584	585	-	-	I-NP	HYPH	B-protein	15	NMOD	B-protein
T9	B-Protein	B-Protein	585	595	CD3epsilon	CD3epsilon	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	596	599	mAb	mAb	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	600	604	OKT3	OKT3	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	605	609	plus	plus	O	CC	O	18	NMOD	O
O	O	O	610	613	PMA	PMA	B-NP	NN	O	11	OBJ	O
O	O	O	614	616	or	or	B-PP	CC	O	18	NMOD	O
O	O	O	617	621	with	with	B-PP	IN	O	19	PMOD	O
O	O	O	622	625	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	626	632	lectin	lectin	I-NP	NN	B-protein	23	NMOD	B-protein
T10	B-Protein	B-Protein	633	636	PHA	PHA	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	637	641	plus	plus	O	CC	O	25	NMOD	O
O	O	O	642	645	PMA	PMA	B-NP	NN	O	20	PMOD	O
O	O	O	646	658	demonstrated	demonstrate	B-VP	VBD	O	1	SBAR	O
O	O	O	659	671	considerable	considerable	B-NP	JJ	O	28	NMOD	O
O	O	O	672	681	increases	increase	I-NP	NNS	O	26	OBJ	O
O	O	O	682	684	in	in	B-PP	IN	O	28	NMOD	O
T11	B-Protein	B-Protein	685	686	c	c	B-NP	NN	B-protein	34	NMOD	B-protein
T11	I-Protein	I-Protein	686	687	-	-	I-NP	HYPH	I-protein	34	NMOD	I-protein
T11	I-Protein	I-Protein	687	690	Fos	Fos	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	691	698	protein	protein	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	699	709	expression	expression	I-NP	NN	O	29	PMOD	O
O	O	O	709	710	,	,	O	,	O	47	P	O
O	O	O	711	714	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	715	725	expression	expression	I-NP	NN	O	47	SUB	O
O	O	O	726	728	of	of	B-PP	IN	O	37	NMOD	O
T12	B-Protein	B-Protein	729	730	c	c	B-NP	NN	B-protein	46	NMOD	B-protein
T12	I-Protein	I-Protein	730	731	-	-	O	HYPH	I-protein	46	NMOD	I-protein
T12	I-Protein	I-Protein	731	734	Fos	Fos	B-NP	NN	I-protein	46	NMOD	I-protein
O	O	O	735	738	but	but	B-NP	CC	O	46	NMOD	O
O	O	O	739	742	not	not	I-NP	RB	O	42	DEP	O
T13	B-Protein	B-Protein	743	744	c	c	B-VP	NN	O	46	NMOD	O
T13	I-Protein	I-Protein	744	745	-	-	B-NP	HYPH	O	46	NMOD	O
T13	I-Protein	I-Protein	745	748	Jun	Jun	I-NP	NN	B-protein	38	PMOD	B-protein
O	O	O	749	752	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	753	761	markedly	markedly	I-VP	RB	O	47	VMOD	O
O	O	O	762	769	reduced	reduce	I-VP	VBN	O	47	VC	O
O	O	O	770	772	in	in	B-PP	IN	O	49	VMOD	O
O	O	O	773	783	stimulated	stimulate	B-NP	VBN	B-cell_type	53	NMOD	B-cell_type
O	O	O	784	785	T	T	I-NP	NN	I-cell_type	53	NMOD	I-cell_type
O	O	O	786	791	cells	cell	I-NP	NNS	I-cell_type	50	PMOD	I-cell_type
O	O	O	792	796	from	from	B-PP	IN	O	53	NMOD	O
O	O	O	797	804	certain	certain	B-NP	JJ	O	57	NMOD	O
O	O	O	805	812	elderly	elderly	I-NP	JJ	O	57	NMOD	O
O	O	O	813	821	subjects	subject	I-NP	NNS	O	54	PMOD	O
O	O	O	821	822	.	.	O	.	O	47	P	O

O	O	O	823	825	In	In	B-PP	IN	O	7	VMOD	O
O	O	O	826	834	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	834	835	,	,	O	,	O	7	P	O
O	O	O	836	841	RNase	RNase	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	842	852	protection	protection	I-NP	NN	O	6	NMOD	O
O	O	O	853	859	assays	assay	I-NP	NNS	O	7	SUB	O
O	O	O	860	868	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	869	873	that	that	B-SBAR	IN	O	7	VMOD	O
O	O	O	874	878	anti	anti	B-NP	AFX	O	17	NMOD	O
O	O	O	878	879	-	-	I-NP	HYPH	O	17	NMOD	O
T30	B-Entity	B-Entity	879	882	CD3	CD3	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	882	883	/	/	B-NP	SYM	O	17	NMOD	O
O	O	O	883	886	PMA	PMA	I-NP	NN	O	17	NMOD	O
O	O	O	886	887	-	-	B-NP	HYPH	O	17	NMOD	O
O	O	O	887	897	stimulated	stimulate	I-NP	VBN	O	17	NMOD	O
O	O	O	898	899	T	T	I-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	O	900	905	cells	cell	I-NP	NNS	I-cell_type	25	SUB	I-cell_type
O	O	O	906	910	from	from	B-PP	IN	O	17	NMOD	O
O	O	O	911	912	a	a	B-NP	DT	O	21	NMOD	O
O	O	O	913	924	substantial	substantial	I-NP	JJ	O	21	NMOD	O
O	O	O	925	935	proportion	proportion	I-NP	NN	O	18	PMOD	O
O	O	O	936	938	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	939	946	elderly	elderly	B-NP	JJ	O	24	NMOD	O
O	O	O	947	955	subjects	subject	I-NP	NNS	O	22	PMOD	O
O	O	O	956	965	exhibited	exhibit	B-VP	VBD	O	8	SBAR	O
O	O	O	966	975	decreased	decrease	B-NP	VBN	O	27	NMOD	O
O	O	O	976	982	levels	level	I-NP	NNS	O	25	OBJ	O
O	O	O	983	985	of	of	B-PP	IN	O	27	NMOD	O
T14	B-Protein	B-Protein	986	987	c	c	B-NP	NN	B-DNA	31	NMOD	B-DNA
T14	I-Protein	I-Protein	987	988	-	-	B-NP	HYPH	I-DNA	31	NMOD	I-DNA
T14	I-Protein	I-Protein	988	991	fos	fos	I-NP	NN	I-DNA	28	PMOD	I-DNA
O	O	O	992	995	and	and	O	CC	O	38	NMOD	O
O	O	O	995	996	/	/	B-NP	SYM	O	38	NMOD	O
O	O	O	996	998	or	or	O	CC	O	38	NMOD	O
T15	B-Protein	B-Protein	999	1000	c	c	O	NN	O	38	NMOD	O
T15	I-Protein	I-Protein	1000	1001	-	-	O	HYPH	O	38	NMOD	O
T15	I-Protein	I-Protein	1001	1004	jun	jun	B-NP	NN	B-RNA	38	NMOD	B-RNA
O	O	O	1005	1009	mRNA	mRNA	I-NP	NN	I-RNA	25	OBJ	I-RNA
O	O	O	1010	1018	compared	compare	B-VP	VBN	O	38	NMOD	O
O	O	O	1019	1021	to	to	B-PP	TO	O	39	VMOD	O
O	O	O	1022	1023	T	T	B-NP	NN	B-cell_type	42	NMOD	B-cell_type
O	O	O	1024	1029	cells	cell	I-NP	NNS	I-cell_type	40	PMOD	I-cell_type
O	O	O	1030	1034	from	from	B-PP	IN	O	42	NMOD	O
O	O	O	1035	1040	young	young	B-NP	JJ	O	45	NMOD	O
O	O	O	1041	1049	subjects	subject	I-NP	NNS	O	43	PMOD	O
O	O	O	1049	1050	.	.	O	.	O	7	P	O

O	O	O	1051	1056	Using	Use	B-VP	VBG	O	44	VMOD	O
O	O	O	1057	1072	electrophoretic	electrophoretic	B-NP	JJ	O	5	NMOD	O
O	O	O	1073	1081	mobility	mobility	I-NP	NN	O	5	NMOD	O
O	O	O	1082	1087	shift	shift	I-NP	NN	O	5	NMOD	O
O	O	O	1088	1094	assays	assay	I-NP	NNS	O	1	OBJ	O
O	O	O	1094	1095	,	,	O	,	O	44	P	O
O	O	O	1096	1099	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1100	1106	levels	level	I-NP	NNS	O	40	NMOD	O
O	O	O	1107	1109	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1110	1117	nuclear	nuclear	B-NP	JJ	B-protein	12	NMOD	B-protein
O	O	O	1118	1128	regulatory	regulatory	I-NP	JJ	I-protein	12	NMOD	I-protein
O	O	O	1129	1137	proteins	protein	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	O	1138	1149	recognizing	recognize	B-VP	VBG	O	12	NMOD	O
O	O	O	1150	1153	the	the	B-NP	DT	O	20	NMOD	O
T31,T32	B-Entity,B-Entity	B-Entity,B-Entity	1154	1156	AP	AP	I-NP	NN	B-DNA	20	NMOD	B-DNA
T31,T32	I-Entity,I-Entity	I-Entity,I-Entity	1156	1157	-	-	B-NP	HYPH	I-DNA	20	NMOD	I-DNA
T31,T32	I-Entity,I-Entity	I-Entity,I-Entity	1157	1158	1	1	I-NP	CD	I-DNA	20	NMOD	I-DNA
T31	I-Entity	I-Entity	1159	1168	consensus	consensus	I-NP	NN	I-DNA	20	NMOD	I-DNA
T31	I-Entity	I-Entity	1169	1172	TRE	TRE	I-NP	NN	I-DNA	20	NMOD	I-DNA
T31	I-Entity	I-Entity	1173	1178	motif	motif	I-NP	NN	I-DNA	31	NMOD	I-DNA
O	O	O	1178	1179	,	,	O	,	O	31	P	O
O	O	O	1180	1183	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	1184	1192	proximal	proximal	I-NP	JJ	B-DNA	31	NMOD	B-DNA
T16	B-Protein	B-Protein	1193	1194	c	c	I-NP	NN	I-DNA	31	NMOD	I-DNA
T16	I-Protein	I-Protein	1194	1195	-	-	O	HYPH	I-DNA	31	NMOD	I-DNA
T16	I-Protein	I-Protein	1195	1198	jun	jun	B-NP	NN	I-DNA	27	NMOD	I-DNA
T33	B-Entity	B-Entity	1199	1202	TRE	TRE	I-NP	NN	I-DNA	31	NMOD	I-DNA
T33	I-Entity	I-Entity	1202	1203	-	-	B-NP	HYPH	I-DNA	31	NMOD	I-DNA
T33	I-Entity	I-Entity	1203	1207	like	like	I-NP	JJ	I-DNA	31	NMOD	I-DNA
T33	I-Entity	I-Entity	1208	1216	promoter	promoter	I-NP	NN	I-DNA	31	NMOD	I-DNA
T33	I-Entity	I-Entity	1217	1224	element	element	I-NP	NN	I-DNA	13	OBJ	I-DNA
O	O	O	1224	1225	,	,	O	,	O	40	P	O
O	O	O	1226	1229	and	and	O	CC	O	40	NMOD	O
O	O	O	1230	1233	the	the	B-NP	DT	O	40	NMOD	O
T17	B-Protein	B-Protein	1234	1235	c	c	I-NP	NN	B-DNA	40	NMOD	B-DNA
T17	I-Protein	I-Protein	1235	1236	-	-	B-NP	HYPH	I-DNA	40	NMOD	I-DNA
T17	I-Protein	I-Protein	1236	1239	fos	fos	I-NP	NN	I-DNA	40	NMOD	I-DNA
T34	B-Entity	B-Entity	1240	1245	serum	serum	I-NP	NN	I-DNA	40	NMOD	I-DNA
T34	I-Entity	I-Entity	1246	1254	response	response	I-NP	NN	I-DNA	40	NMOD	I-DNA
T34	I-Entity	I-Entity	1255	1262	element	element	I-NP	NN	I-DNA	44	SUB	I-DNA
O	O	O	1263	1264	(	(	O	(	O	43	DEP	O
T35	B-Entity	B-Entity	1264	1267	SRE	SRE	B-NP	NN	B-DNA	43	DEP	B-DNA
O	O	O	1267	1268	)	)	O	)	O	40	NMOD	O
O	O	O	1269	1273	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1274	1284	determined	determine	I-VP	VBN	O	44	VC	O
O	O	O	1285	1287	in	in	B-PP	IN	O	45	VMOD	O
O	O	O	1288	1295	resting	rest	B-NP	VBG	B-cell_type	51	NMOD	B-cell_type
O	O	O	1296	1299	and	and	I-NP	CC	I-cell_type	51	NMOD	I-cell_type
O	O	O	1300	1310	stimulated	stimulate	I-NP	VBN	I-cell_type	51	NMOD	I-cell_type
O	O	O	1311	1312	T	T	I-NP	NN	I-cell_type	51	NMOD	I-cell_type
O	O	O	1313	1318	cells	cell	I-NP	NNS	I-cell_type	46	PMOD	I-cell_type
O	O	O	1318	1319	.	.	O	.	O	44	P	O

O	O	O	1320	1328	Although	Although	B-SBAR	IN	O	50	VMOD	O
O	O	O	1329	1332	the	the	B-NP	DT	O	3	NMOD	O
O	O	O	1333	1344	stimulation	stimulation	I-NP	NN	O	1	SUB	O
O	O	O	1345	1347	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	1348	1349	T	T	B-NP	NN	B-cell_type	6	NMOD	B-cell_type
O	O	O	1350	1355	cells	cell	I-NP	NNS	I-cell_type	4	PMOD	I-cell_type
O	O	O	1356	1360	from	from	B-PP	IN	O	6	NMOD	O
O	O	O	1361	1366	young	young	B-NP	JJ	O	9	NMOD	O
O	O	O	1367	1375	subjects	subject	I-NP	NNS	O	7	PMOD	O
O	O	O	1376	1384	resulted	result	B-VP	VBD	O	1	SBAR	O
O	O	O	1385	1387	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	1388	1399	coordinated	coordinate	B-NP	VBN	O	13	NMOD	O
O	O	O	1400	1409	increases	increase	I-NP	NNS	O	11	PMOD	O
O	O	O	1410	1412	of	of	B-PP	IN	O	13	NMOD	O
T36	B-Entity	B-Entity	1413	1420	nuclear	nuclear	B-NP	JJ	B-protein	17	NMOD	B-protein
T36	I-Entity	I-Entity	1421	1428	protein	protein	I-NP	NN	I-protein	17	NMOD	I-protein
T36	I-Entity	I-Entity	1429	1438	complexes	complex	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	O	1439	1446	binding	bind	B-VP	VBG	O	17	NMOD	O
O	O	O	1447	1450	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	1451	1453	AP	AP	I-NP	NN	B-DNA	23	NMOD	B-DNA
O	O	O	1453	1454	-	-	B-NP	HYPH	I-DNA	23	NMOD	I-DNA
O	O	O	1454	1455	1	1	I-NP	CD	I-DNA	23	NMOD	I-DNA
O	O	O	1456	1459	TRE	TRE	I-NP	NN	I-DNA	37	NMOD	I-DNA
O	O	O	1459	1460	,	,	O	,	O	37	P	O
T18	B-Protein	B-Protein	1461	1462	c	c	B-NP	NN	O	28	NMOD	O
T18	I-Protein	I-Protein	1462	1463	-	-	I-NP	HYPH	O	28	NMOD	O
T18	I-Protein	I-Protein	1463	1466	jun	jun	I-NP	NN	B-DNA	28	NMOD	B-DNA
O	O	O	1467	1470	TRE	TRE	I-NP	NN	I-DNA	37	NMOD	I-DNA
O	O	O	1470	1471	,	,	O	,	O	37	P	O
O	O	O	1472	1475	and	and	O	CC	O	37	NMOD	O
T19	B-Protein	B-Protein	1476	1477	c	c	B-NP	NN	B-DNA	37	NMOD	B-DNA
T19	I-Protein	I-Protein	1477	1478	-	-	I-NP	HYPH	I-DNA	37	NMOD	I-DNA
T19	I-Protein	I-Protein	1478	1481	fos	fos	I-NP	NN	I-DNA	37	NMOD	I-DNA
O	O	O	1482	1485	SRE	SRE	I-NP	NN	I-DNA	37	NMOD	I-DNA
T37	B-Entity	B-Entity	1486	1489	DNA	DNA	I-NP	NN	I-DNA	37	NMOD	I-DNA
T37	I-Entity	I-Entity	1490	1498	sequence	sequence	I-NP	NN	I-DNA	37	NMOD	I-DNA
T37	I-Entity	I-Entity	1499	1505	motifs	motif	I-NP	NNS	I-DNA	18	OBJ	I-DNA
O	O	O	1505	1506	,	,	O	,	O	50	P	O
O	O	O	1507	1510	age	age	B-NP	NN	O	42	NMOD	O
O	O	O	1510	1511	-	-	O	HYPH	O	42	P	O
O	O	O	1511	1518	related	relate	B-NP	VBN	O	42	NMOD	O
O	O	O	1519	1529	reductions	reduction	I-NP	NNS	O	50	SUB	O
O	O	O	1530	1532	in	in	B-PP	IN	O	42	NMOD	O
O	O	O	1533	1536	the	the	B-NP	DT	O	45	NMOD	O
O	O	O	1537	1547	activation	activation	I-NP	NN	O	43	PMOD	O
O	O	O	1548	1550	of	of	B-PP	IN	O	45	NMOD	O
T38	B-Entity	B-Entity	1551	1553	AP	AP	B-NP	NN	B-protein	48	NMOD	B-protein
T38	I-Entity	I-Entity	1553	1554	-	-	B-NP	HYPH	I-protein	46	PMOD	I-protein
T38	I-Entity	I-Entity	1554	1555	1	1	I-NP	CD	I-protein	48	NMOD	I-protein
O	O	O	1556	1560	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1561	1572	accompanied	accompany	I-VP	VBN	O	50	VC	O
O	O	O	1573	1575	by	by	B-PP	IN	O	51	VMOD	O
O	O	O	1576	1585	decreased	decrease	B-NP	VBN	O	54	NMOD	O
O	O	O	1586	1592	levels	level	I-NP	NNS	O	52	PMOD	O
O	O	O	1593	1595	of	of	B-PP	IN	O	54	NMOD	O
T20	B-Protein	B-Protein	1596	1597	c	c	B-NP	NN	B-protein	66	NMOD	B-protein
T20	I-Protein	I-Protein	1597	1598	-	-	O	HYPH	I-protein	66	P	I-protein
T20	I-Protein	I-Protein	1598	1601	jun	jun	B-NP	NN	I-protein	59	NMOD	I-protein
O	O	O	1602	1605	TRE	TRE	I-NP	NN	I-protein	66	NMOD	I-protein
O	O	O	1606	1609	and	and	O	CC	I-protein	66	NMOD	I-protein
T21	B-Protein	B-Protein	1610	1611	c	c	B-NP	NN	I-protein	66	NMOD	I-protein
T21	I-Protein	I-Protein	1611	1612	-	-	I-NP	HYPH	I-protein	66	NMOD	I-protein
T21	I-Protein	I-Protein	1612	1615	fos	fos	I-NP	NN	I-protein	66	NMOD	I-protein
O	O	O	1616	1619	SRE	SRE	I-NP	NN	I-protein	66	NMOD	I-protein
T39	B-Entity	B-Entity	1620	1627	binding	binding	I-NP	NN	I-protein	66	NMOD	I-protein
T39	I-Entity	I-Entity	1628	1637	complexes	complex	I-NP	NNS	I-protein	55	PMOD	I-protein
O	O	O	1637	1638	.	.	O	.	O	50	P	O

O	O	O	1639	1650	Furthermore	Furthermore	B-ADVP	RB	O	21	VMOD	O
O	O	O	1650	1651	,	,	O	,	O	21	P	O
O	O	O	1652	1655	the	the	B-NP	DT	O	6	NMOD	O
T40	B-Entity	B-Entity	1656	1663	nuclear	nuclear	I-NP	JJ	B-protein	6	NMOD	B-protein
T40	I-Entity	I-Entity	1664	1671	protein	protein	I-NP	NN	I-protein	6	NMOD	I-protein
T40	I-Entity	I-Entity	1672	1681	complexes	complex	I-NP	NNS	I-protein	21	SUB	I-protein
O	O	O	1682	1689	binding	bind	B-VP	VBG	O	6	NMOD	O
O	O	O	1690	1693	the	the	B-NP	DT	O	10	NMOD	O
T41	B-Entity	B-Entity	1694	1697	SRE	SRE	I-NP	NN	B-DNA	10	NMOD	B-DNA
T41	I-Entity	I-Entity	1698	1703	motif	motif	I-NP	NN	I-DNA	7	OBJ	I-DNA
O	O	O	1704	1711	induced	induce	B-VP	VBN	O	10	NMOD	O
O	O	O	1712	1714	in	in	B-PP	IN	O	11	VMOD	O
O	O	O	1715	1724	activated	activate	B-NP	VBN	B-cell_type	15	NMOD	B-cell_type
O	O	O	1725	1726	T	T	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	O	1727	1732	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	O	1733	1735	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	1736	1741	young	young	B-NP	JJ	O	20	NMOD	O
O	O	O	1742	1745	and	and	I-NP	CC	O	20	NMOD	O
O	O	O	1746	1753	elderly	elderly	I-NP	JJ	O	20	NMOD	O
O	O	O	1754	1762	subjects	subject	I-NP	NNS	O	16	PMOD	O
O	O	O	1763	1772	contained	contain	B-VP	VBD	O	0	ROOT	O
T22	B-Protein	B-Protein	1773	1778	serum	serum	B-NP	NN	B-protein	24	NMOD	B-protein
T22	I-Protein	I-Protein	1779	1787	response	response	I-NP	NN	I-protein	24	NMOD	I-protein
T22	I-Protein	I-Protein	1788	1794	factor	factor	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	1795	1798	and	and	I-NP	CC	O	26	NMOD	O
T23	B-Protein	B-Protein	1799	1802	Elk	Elk	I-NP	NN	B-protein	29	NMOD	B-protein
T23	I-Protein	I-Protein	1802	1803	-	-	B-NP	HYPH	O	29	NMOD	O
T23	I-Protein	I-Protein	1803	1804	1	1	I-NP	CD	O	29	NMOD	O
O	O	O	1805	1813	pointing	pointing	I-NP	NN	O	21	OBJ	O
O	O	O	1814	1820	toward	toward	B-PP	IN	O	29	NMOD	O
O	O	O	1821	1824	age	age	B-NP	NN	O	34	NMOD	O
O	O	O	1824	1825	-	-	B-NP	HYPH	O	34	NMOD	O
O	O	O	1825	1832	related	relate	I-NP	VBN	O	34	NMOD	O
O	O	O	1833	1840	defects	defect	I-NP	NNS	O	30	PMOD	O
O	O	O	1841	1843	in	in	B-PP	IN	O	34	NMOD	O
O	O	O	1844	1847	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	1848	1858	activation	activation	I-NP	NN	O	35	PMOD	O
O	O	O	1859	1861	of	of	B-PP	IN	O	37	NMOD	O
O	O	O	1862	1877	transcriptional	transcriptional	B-NP	JJ	B-protein	41	NMOD	B-protein
O	O	O	1878	1888	regulatory	regulatory	I-NP	JJ	I-protein	41	NMOD	I-protein
O	O	O	1889	1897	proteins	protein	I-NP	NNS	I-protein	38	PMOD	I-protein
O	O	O	1898	1906	distinct	distinct	B-ADJP	JJ	O	41	NMOD	O
O	O	O	1907	1911	from	from	B-PP	IN	O	42	AMOD	O
T24	B-Protein	B-Protein	1912	1913	c	c	B-NP	NN	B-DNA	49	NMOD	B-DNA
T24	I-Protein	I-Protein	1913	1914	-	-	I-NP	HYPH	I-DNA	49	NMOD	I-DNA
T24	I-Protein	I-Protein	1914	1917	jun	jun	I-NP	NN	I-DNA	49	NMOD	I-DNA
T42	B-Entity	B-Entity	1917	1918	/	/	O	SYM	O	49	P	O
T42	I-Entity	I-Entity	1918	1920	AP	AP	B-NP	NN	B-protein	49	NMOD	B-protein
T42	I-Entity	I-Entity	1920	1921	-	-	B-NP	SYM	I-protein	43	PMOD	I-protein
T42	I-Entity	I-Entity	1921	1922	1	1	I-NP	CD	I-protein	49	NMOD	I-protein
O	O	O	1922	1923	.	.	O	.	O	21	P	O

O	O	O	1924	1929	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1930	1937	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1938	1945	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1946	1950	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1951	1961	underlying	underlie	B-VP	VBG	O	6	NMOD	O
O	O	O	1962	1973	aberrancies	aberrancy	B-NP	NNS	O	25	SUB	O
O	O	O	1974	1976	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	1977	1980	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1981	1990	induction	induction	I-NP	NN	O	7	PMOD	O
O	O	O	1991	1993	of	of	B-PP	IN	O	9	NMOD	O
T25	B-Protein	B-Protein	1994	1995	c	c	B-NP	NN	B-DNA	24	NMOD	B-DNA
T25	I-Protein	I-Protein	1995	1996	-	-	I-NP	HYPH	I-DNA	24	NMOD	I-DNA
T25	I-Protein	I-Protein	1996	1999	fos	fos	I-NP	NN	I-DNA	24	NMOD	I-DNA
O	O	O	1999	2000	/	/	B-NP	SYM	O	24	NMOD	O
T26	B-Protein	B-Protein	2000	2001	c	c	I-NP	NN	O	24	NMOD	O
T26	I-Protein	I-Protein	2001	2002	-	-	B-NP	HYPH	O	24	NMOD	O
T26	I-Protein	I-Protein	2002	2005	jun	jun	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	2006	2008	as	as	B-CONJP	RB	O	24	NMOD	O
O	O	O	2009	2013	well	well	I-CONJP	RB	O	18	DEP	O
O	O	O	2014	2016	as	as	I-CONJP	IN	O	18	DEP	O
O	O	O	2017	2022	their	their	B-NP	PRP$	O	24	NMOD	O
O	O	O	2023	2030	nuclear	nuclear	I-NP	JJ	B-protein	24	NMOD	B-protein
O	O	O	2031	2041	regulatory	regulatory	I-NP	JJ	I-protein	24	NMOD	I-protein
O	O	O	2042	2050	proteins	protein	I-NP	NNS	I-protein	10	PMOD	I-protein
O	O	O	2051	2054	may	may	B-VP	MD	O	4	SBAR	O
O	O	O	2055	2065	contribute	contribute	I-VP	VB	O	25	VC	O
O	O	O	2066	2068	to	to	B-PP	TO	O	26	VMOD	O
O	O	O	2069	2072	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	2073	2076	age	age	I-NP	NN	O	32	NMOD	O
O	O	O	2076	2077	-	-	B-NP	HYPH	O	32	NMOD	O
O	O	O	2077	2084	related	relate	I-NP	VBN	O	32	NMOD	O
O	O	O	2085	2096	impairments	impairment	I-NP	NNS	O	27	PMOD	O
O	O	O	2097	2099	of	of	B-PP	IN	O	32	NMOD	O
T43	B-Entity	B-Entity	2100	2102	AP	AP	B-NP	NN	B-protein	37	NMOD	B-protein
T43	I-Entity	I-Entity	2102	2103	-	-	B-NP	HYPH	I-protein	37	NMOD	I-protein
T43	I-Entity	I-Entity	2103	2104	1	1	I-NP	CD	I-protein	37	NMOD	I-protein
O	O	O	2105	2115	activation	activation	I-NP	NN	O	33	PMOD	O
O	O	O	2116	2118	in	in	B-PP	IN	O	37	NMOD	O
O	O	O	2119	2124	human	human	B-NP	JJ	B-cell_type	41	NMOD	B-cell_type
O	O	O	2125	2126	T	T	I-NP	NN	I-cell_type	41	NMOD	I-cell_type
O	O	O	2127	2132	cells	cell	I-NP	NNS	I-cell_type	38	PMOD	I-cell_type
O	O	O	2132	2133	.	.	O	.	O	3	P	O
